PHH

Park Ha Biological Technology Co., Ltd. Ordinary Shares
PHH
Market cap $330M

12.50 USD

-0.72

5.45%

Updated Apr 1, 2:36 PM EDT

1 day

-5.45%

5 days

30.62%

1 month

114.78%

3 months

171.74%

6 months

207.13%

Year to date

171.74%

1 year

207.13%

5 years

207.13%

10 years

-48.50%

Materials Soap, Detergents, Cleaning Preparations, Perfumes, Cosmetics

0

Funds holding %

of 7,398 funds

–

Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

0.31% more ownership

Funds ownership: 0% [Q3] → 0.31% (+0.31%) [Q4]

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for PHH.

See Analyst Rankings

Financial journalist opinion

Park Ha Biological Technology Co., Ltd. Announces Closing of $4.8 Million Initial Public Offering

Wuxi, China, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (Nasdaq: PHH) (the “Company”), a company focused on developing private skincare labels, direct skincare product sales, and franchise alliance promotions, today announced the closing of its initial public offering (the “Offering”) of 1,200,000 ordinary shares (the “Ordinary Shares”) at a public offering price of $4.00 per ordinary share. The Ordinary Shares began trading on the Nasdaq Capital Market on December 27, 2024 under the ticker symbol “PHH.”

Park Ha Biological Technology Co., Ltd. Announces Closing of $4.8 Million Initial Public Offering

Park Ha Biological Technology Co., Ltd. Announces Pricing of $4.8 Million Initial Public Offering

Wuxi, China, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (the "Company"), a company focused on developing private skincare labels, direct skincare product sales, and franchise alliance promotions, today announced the pricing of its initial public offering (the "Offering") of 1,200,000 ordinary shares at a public offering price of $4.00 per ordinary share. The ordinary shares have been approved for listing on the Nasdaq Capital Market and are expected to commence trading on December 27, 2024 under the ticker symbol "PHH."

Park Ha Biological Technology Co., Ltd. Announces Pricing of $4.8 Million Initial Public Offering

Park Ha Biological Aims For U.S. IPO At Sky-High Valuation

Park Ha Biological Technology Co., Ltd. seeks $6 million in an IPO, but has wildly excessive valuation expectations given its small size and fluctuating financial metrics. The company faces numerous regulatory and market risks, with declining revenues and high franchisee turnover, adding doubt to its business model structure. Park Ha's financial performance shows variable revenue, reduced gross profit and sharply lower cash flow.

Park Ha Biological Aims For U.S. IPO At Sky-High Valuation

U.S. IPO Weekly Recap: Small Issuers Close Out August IPO Market

While major IPOs are on hold until after Labor Day, three small deals were completed in the last week of August. Two SPACs, GigCapital7 and Black Spade Acquisition II, raised $200 million and $150 million, respectively. Three IPOs are currently scheduled to list in the week ahead, all of them holdovers from previous weeks, and all based in the Asia Pacific region.

U.S. IPO Weekly Recap: Small Issuers Close Out August IPO Market

See News Rankings

Charts implemented using Lightweight Charts™